Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuma Iekushi

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Hypertension (Dallas, Tex. : 1979)|January 19, 2012
Telmisartan exerts renoprotective actions via peroxisome proliferator-activated receptor-γ/hepatocyte growth factor pathway independent of angiotensin II type 1 receptor blockadeHiroshi Kusunoki, Yoshiaki Taniyama, Junya Azuma, et al.
Clinical and Experimental Nephrology|November 2, 2025
Diagnosis and treatment in adult patients with C3 glomerulopathy in Japan: a real-world surveyNaoki Nakagawa, Yutaro Kotobuki, Michel Kroes, et al.
Journal of Hypertension|September 16, 2010
Hepatocyte growth factor attenuates renal fibrosis through TGF-β1 suppression by apoptosis of myofibroblastsKazuma Iekushi, Yoshiaki Taniyama, Junya Azuma, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|September 24, 2014
Present profiles of novel anticoagulant use in Japanese patients with atrial fibrillation: insights from the Rivaroxaban Postmarketing Surveillance RegistrySatoshi Ogawa, Takanori Ikeda, Takanari Kitazono, et al.
Critical Care Medicine|January 19, 2010
Preconditioning by toll-like receptor 2 agonist Pam3CSK4 reduces CXCL1-dependent leukocyte recruitment in murine myocardial ischemia/reperfusion injuryJan Mersmann, Reinhard Berkels, Paula Zacharowski, et al.
Hypertension (Dallas, Tex. : 1979)|December 9, 2015
Selective Blockade of Periostin Exon 17 Preserves Cardiac Performance in Acute Myocardial InfarctionYoshiaki Taniyama, Naruto Katsuragi, Fumihiro Sanada, et al.
Thrombosis Journal|February 27, 2015
Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism - the J-EINSTEIN DVT and PE programNorikazu Yamada, Atsushi Hirayama, Hideaki Maeda, et al.
Journal of the American College of Cardiology|June 2, 2012
Micro-RNA-34a contributes to the impaired function of bone marrow-derived mononuclear cells from patients with cardiovascular diseaseQuanfu Xu, Florian H Seeger, Jessica Castillo, et al.
Journal of Cardiology|January 23, 2016
Predictive factors for bleeding during treatment with rivaroxaban and warfarin in Japanese patients with atrial fibrillation - Subgroup analysis of J-ROCKET AFMasatsugu Hori, Masayasu Matsumoto, Norio Tanahashi, et al.
Thrombosis Journal|May 26, 2016
Erratum to: 'Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism - the J-EINSTEIN DVT and PE program'Norikazu Yamada, Atsushi Hirayama, Hideaki Maeda, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Hypertension (Dallas, Tex. : 1979)|January 19, 2012
Telmisartan exerts renoprotective actions via peroxisome proliferator-activated receptor-γ/hepatocyte growth factor pathway independent of angiotensin II type 1 receptor blockadeHiroshi Kusunoki, Yoshiaki Taniyama, Junya Azuma, et al.
Clinical and Experimental Nephrology|November 2, 2025
Diagnosis and treatment in adult patients with C3 glomerulopathy in Japan: a real-world surveyNaoki Nakagawa, Yutaro Kotobuki, Michel Kroes, et al.
Journal of Hypertension|September 16, 2010
Hepatocyte growth factor attenuates renal fibrosis through TGF-β1 suppression by apoptosis of myofibroblastsKazuma Iekushi, Yoshiaki Taniyama, Junya Azuma, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|September 24, 2014
Present profiles of novel anticoagulant use in Japanese patients with atrial fibrillation: insights from the Rivaroxaban Postmarketing Surveillance RegistrySatoshi Ogawa, Takanori Ikeda, Takanari Kitazono, et al.
Critical Care Medicine|January 19, 2010
Preconditioning by toll-like receptor 2 agonist Pam3CSK4 reduces CXCL1-dependent leukocyte recruitment in murine myocardial ischemia/reperfusion injuryJan Mersmann, Reinhard Berkels, Paula Zacharowski, et al.
Hypertension (Dallas, Tex. : 1979)|December 9, 2015
Selective Blockade of Periostin Exon 17 Preserves Cardiac Performance in Acute Myocardial InfarctionYoshiaki Taniyama, Naruto Katsuragi, Fumihiro Sanada, et al.
Thrombosis Journal|February 27, 2015
Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism - the J-EINSTEIN DVT and PE programNorikazu Yamada, Atsushi Hirayama, Hideaki Maeda, et al.
Journal of the American College of Cardiology|June 2, 2012
Micro-RNA-34a contributes to the impaired function of bone marrow-derived mononuclear cells from patients with cardiovascular diseaseQuanfu Xu, Florian H Seeger, Jessica Castillo, et al.
Journal of Cardiology|January 23, 2016
Predictive factors for bleeding during treatment with rivaroxaban and warfarin in Japanese patients with atrial fibrillation - Subgroup analysis of J-ROCKET AFMasatsugu Hori, Masayasu Matsumoto, Norio Tanahashi, et al.
Thrombosis Journal|May 26, 2016
Erratum to: 'Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism - the J-EINSTEIN DVT and PE program'Norikazu Yamada, Atsushi Hirayama, Hideaki Maeda, et al.
Pageof 5